Mithrl raises $20 million in a Series A round led by Obvious Ventures to advance its custom AI infrastructure for biopharma.
Amount Raised
$20 Million
Round Type
Series A
San FranciscoBiotechnologyArtificial IntelligenceMachine LearningInvestors
Description
Mithrl, the AI infrastructure company for biopharma, announced a $20 million Series A round. The funding, led by Obvious Ventures and supported by other investors, will enhance Mithrl's second-generation platform. This platform utilizes a proprietary biomedical world model integrated with advanced AI technologies. The goal is to optimize AI infrastructure in the biopharmaceutical sector.
Who to call at Mithril Medicine, and when
A new round usually means Mithril Medicine is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Mithril Medicine raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Mithril Medicine, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Mithril Medicine. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Mithril Medicine raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansMithril Medicine raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.